Therapeutic Effects and Adverse Drug Reactions are Affected by Icotinib Exposure and CYP2C19 and EGFR Genotypes in Chinese Non-Small Cell Lung Cancer Patients-Reference-Cited by-同舟云学术

Therapeutic Effects and Adverse Drug Reactions are Affected by Icotinib Exposure and CYP2C19 and EGFR Genotypes in Chinese Non-Small Cell Lung Cancer Patients

Published:2014-09-15 Issue:17 Volume:15 Page:7195-7200
ISSN:1513-7368
Container-title:Asian Pacific Journal of Cancer Prevention
language:en
Short-container-title:Asian Pacific Journal of Cancer Prevention

Author:

Chen Jia,Zheng Xin,Liu Dong-Yang,Zhao Qian,Wu Yi-Wen,Tan Fen-Lai,Wang Yin-Xiang,Jiang Ji,Hu Pei

Publisher

Asian Pacific Organization for Cancer Prevention

Subject

Cancer Research,Public Health, Environmental and Occupational Health,Oncology,Epidemiology

Link

http://ocean.kisti.re.kr/downfile/crosscheck/apocp/JAKO201429765166824.pdf

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A fully validated LC‑MS/MS method for quantifying bevacizumab in plasma samples from patients with NSCLC and its implications in therapeutic drug monitoring;Oncology Letters;2024-03-22

2. Determination of Tyrosine Kinase Inhibitor Icotinib in Rat Plasma using UPLC-MS/MS and its Application In vivo Pharmacokinetic;Current Pharmaceutical Analysis;2024-01

3. A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring;Journal of Pharmaceutical and Biomedical Analysis;2023-11

4. An analysis on the clinical features and risk factors associated with the prognosis of patients with drug-induced liver injury;Exploration of Digestive Diseases;2023-06-30

5. Simultaneous quantitative detection of afatinib, erlotinib, gefitinib, icotinib, osimertinib and their metabolites in plasma samples of patients with non-small cell lung cancer using liquid chromatography-tandem mass spectrometry;Clinica Chimica Acta;2022-02